REG - Sampo PLC - Publication of Suppl.Prospcts

Sampo OyjAnnouncement

24/09/2018 13:30

RNS Number : 7275B
Sampo PLC
24 September 2018
 


Sampo plc
 
24 September 2018
 
Publication of Supplement to Prospectus
 
The following Supplement has been approved by the UK Listing Authority:
 
Supplement dated 24 September 2018 to Prospectus dated 13 April 2018 relating to the EUR 4,000,000,000 (increased from EUR 3,500,000,000) Euro Medium Term Note Programme of Sampo plc.
 
The following documents (the "Documents") have been filed with the UK Listing Authority and are available for viewing:
 
Supplement dated 24 September 2018
 
Q2 Interim Report for the six month period ended 30 June 2018
 
The Documents must be read in conjunction with the Prospectus dated 13 April 2018 and any other supplements thereto. The Prospectus constitutes a base prospectus for the purposes of Article 5.4 of Directive 2003/71/EC as amended.  Full information on Sampo plc is only available on the basis of the Prospectus.
 
To view the full documents, please paste the following URL into the address bar of your browser.
 
Supplement dated 24 September 2018
 
http://www.rns-pdf.londonstockexchange.com/rns/7275B_1-2018-9-24.pdf
 
Q2 Interim Report for the six month period ended 30 June 2018
 
http://www.rns-pdf.londonstockexchange.com/rns/7275B_2-2018-9-24.pdf
 
 
 
A copy of the above document has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/nsm
 
For further information, please contact
 
Jarmo Salonen
Head of Investor Relations and Group Communications
Tel:      +358 10 516 0030
 
Sampo plc
Registered Office
Fabianinkatu 27
FI-00100 Helsinki
Finland
 
 
DISCLAIMER - INTENDED ADDRESSEES
 
Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
 
In particular, the Prospectus does not constitute an offer of securities for sale in the United States.  This is not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements.  Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.
 
Your right to access this service is conditional upon complying with the above requirement. 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPPGUCPBUPRGPC